Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism
- 1 May 2018
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 51 (5) , 784-788
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Global molecular epidemiology and genetic diversity of Fusarium , a significant emerging group of human opportunists from 1958 to 2015Emerging Microbes & Infections, 2016
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and othersClinical Microbiology and Infection, 2014
- Antiarrhythmic drug amiodarone displays antifungal activity, induces irregular calcium response and intracellular acidification of Aspergillus niger – Amiodarone targets calcium and pH homeostasis of A. nigerFungal Genetics and Biology, 2012
- In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium sppDiagnostic Microbiology and Infectious Disease, 2011
- In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilmsInternational Journal of Antimicrobial Agents, 2009
- Effects of amiodarone on K+, internal pH and Ca2+homeostasis inSaccharomyces cerevisiaeFEMS Yeast Research, 2009
- Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatusJournal of Antimicrobial Chemotherapy, 2008
- Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungiMicrobiology, 2008
- Antifungal Activity of Nonantifungal DrugsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Characterization of a Novel, Broad-Based Fungicidal Activity for the Antiarrhythmic Drug AmiodaroneThe Journal of Pharmacology and Experimental Therapeutics, 2002